rs200158571
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_015512.5(DNAH1):c.9646C>G(p.Leu3216Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00119 in 1,552,314 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L3216L) has been classified as Likely benign.
Frequency
Consequence
NM_015512.5 missense
Scores
Clinical Significance
Conservation
Publications
- spermatogenic failure 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- ciliary dyskinesia, primary, 37Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- non-syndromic male infertility due to sperm motility disorderInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAH1 | NM_015512.5 | c.9646C>G | p.Leu3216Val | missense_variant | Exon 61 of 78 | ENST00000420323.7 | NP_056327.4 | |
| DNAH1 | XM_017006129.2 | c.9715C>G | p.Leu3239Val | missense_variant | Exon 63 of 80 | XP_016861618.1 | ||
| DNAH1 | XM_017006130.2 | c.9646C>G | p.Leu3216Val | missense_variant | Exon 62 of 79 | XP_016861619.1 | ||
| DNAH1 | XM_017006131.2 | c.9589C>G | p.Leu3197Val | missense_variant | Exon 62 of 79 | XP_016861620.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAH1 | ENST00000420323.7 | c.9646C>G | p.Leu3216Val | missense_variant | Exon 61 of 78 | 1 | NM_015512.5 | ENSP00000401514.2 |
Frequencies
GnomAD3 genomes AF: 0.000749 AC: 114AN: 152224Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000666 AC: 106AN: 159132 AF XY: 0.000608 show subpopulations
GnomAD4 exome AF: 0.00124 AC: 1736AN: 1399972Hom.: 1 Cov.: 32 AF XY: 0.00121 AC XY: 838AN XY: 690540 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000748 AC: 114AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.000792 AC XY: 59AN XY: 74506 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 3216 of the DNAH1 protein (p.Leu3216Val). This variant is present in population databases (rs200158571, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with DNAH1-related conditions. ClinVar contains an entry for this variant (Variation ID: 478516). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DNAH1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Primary ciliary dyskinesia Uncertain:1
- -
Oligosynaptic infertility;C4539798:Ciliary dyskinesia, primary, 37 Other:1
Variant interpreted as Uncertain significance and reported on 06-08-2020 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at